Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chin, Sang Ouk | - |
dc.contributor.author | Ku, Cheol Ryong | - |
dc.contributor.author | Kim, Byung Joon | - |
dc.contributor.author | Kim, Sung-Woon | - |
dc.contributor.author | Park, Kyeong Hye | - |
dc.contributor.author | Song, Kee Ho | - |
dc.contributor.author | Oh, Scungjoon | - |
dc.contributor.author | Yoon, Hyun Koo | - |
dc.contributor.author | Lee, Eun Jig | - |
dc.contributor.author | Lee, Jung Min | - |
dc.contributor.author | Lie, Jung Soo | - |
dc.contributor.author | Kim, Jung Hee | - |
dc.contributor.author | Kim, Kwang Joon | - |
dc.contributor.author | Jin, Heung Yong | - |
dc.contributor.author | Kim, Dae Jung | - |
dc.contributor.author | Lee, Kyung Ae | - |
dc.contributor.author | Moon, Seong-Su | - |
dc.contributor.author | Lim, Dong Jun | - |
dc.contributor.author | Shin, Dong Yeob | - |
dc.contributor.author | Kim, Se Hwa | - |
dc.contributor.author | Kwon, Mm Jeong | - |
dc.contributor.author | Kim, Ha Young | - |
dc.contributor.author | Kim, Jin Hwa | - |
dc.contributor.author | Kim, Dong Sun | - |
dc.contributor.author | Kim, Chong Hwa | - |
dc.date.available | 2020-02-27T04:41:07Z | - |
dc.date.created | 2020-02-04 | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/1793 | - |
dc.description.abstract | The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically increasing. In 2017, the KES Committee of Health Insurance decided to publish a position statement regarding the use of somatostatin analogues in acromegaly. Accordingly, consensus opinions for the position statement were collected after intensive review of the relevant literature and discussions among experts affiliated with the KES, and the Korean Neuroendocrine Study Group. This position statement includes the characteristics, indications, dose, interval (including ex-tended dose interval in case of lanreotide autogel), switching and preoperative use of somatostatin analogues in medical treatment of acromegaly. The recommended approach is based on the expert opinions in case of insufficient clinical evidence, and where discrepancies among the expert opinions were found, the experts voted to determine the recommended approach. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ENDOCRINE SOC | - |
dc.relation.isPartOf | ENDOCRINOLOGY AND METABOLISM | - |
dc.title | Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000462184200007 | - |
dc.identifier.doi | 10.3803/EnM.2019.34.1.53 | - |
dc.identifier.bibliographicCitation | ENDOCRINOLOGY AND METABOLISM, v.34, no.1, pp.53 - 62 | - |
dc.identifier.kciid | ART002452692 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85065031242 | - |
dc.citation.endPage | 62 | - |
dc.citation.startPage | 53 | - |
dc.citation.title | ENDOCRINOLOGY AND METABOLISM | - |
dc.citation.volume | 34 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Kim, Byung Joon | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Acromegaly | - |
dc.subject.keywordAuthor | Somatostatin analogues | - |
dc.subject.keywordAuthor | Octreotide | - |
dc.subject.keywordAuthor | Lanreotide | - |
dc.subject.keywordAuthor | Pasireotide | - |
dc.subject.keywordPlus | AUTOGEL 120 MG | - |
dc.subject.keywordPlus | LONG-ACTING RELEASE | - |
dc.subject.keywordPlus | PREOPERATIVE OCTREOTIDE TREATMENT | - |
dc.subject.keywordPlus | SECRETING PITUITARY-ADENOMAS | - |
dc.subject.keywordPlus | GROWTH-FACTOR-I | - |
dc.subject.keywordPlus | LANREOTIDE AUTOGEL | - |
dc.subject.keywordPlus | TRANSSPHENOIDAL SURGERY | - |
dc.subject.keywordPlus | RECEPTOR LIGANDS | - |
dc.subject.keywordPlus | CUSHINGS-DISEASE | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.